R-MINE regimen

Jump to navigation Jump to search

WikiDoc Resources for R-MINE regimen

Articles

Most recent articles on R-MINE regimen

Most cited articles on R-MINE regimen

Review articles on R-MINE regimen

Articles on R-MINE regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on R-MINE regimen

Images of R-MINE regimen

Photos of R-MINE regimen

Podcasts & MP3s on R-MINE regimen

Videos on R-MINE regimen

Evidence Based Medicine

Cochrane Collaboration on R-MINE regimen

Bandolier on R-MINE regimen

TRIP on R-MINE regimen

Clinical Trials

Ongoing Trials on R-MINE regimen at Clinical Trials.gov

Trial results on R-MINE regimen

Clinical Trials on R-MINE regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on R-MINE regimen

NICE Guidance on R-MINE regimen

NHS PRODIGY Guidance

FDA on R-MINE regimen

CDC on R-MINE regimen

Books

Books on R-MINE regimen

News

R-MINE regimen in the news

Be alerted to news on R-MINE regimen

News trends on R-MINE regimen

Commentary

Blogs on R-MINE regimen

Definitions

Definitions of R-MINE regimen

Patient Resources / Community

Patient resources on R-MINE regimen

Discussion groups on R-MINE regimen

Patient Handouts on R-MINE regimen

Directions to Hospitals Treating R-MINE regimen

Risk calculators and risk factors for R-MINE regimen

Healthcare Provider Resources

Symptoms of R-MINE regimen

Causes & Risk Factors for R-MINE regimen

Diagnostic studies for R-MINE regimen

Treatment of R-MINE regimen

Continuing Medical Education (CME)

CME Programs on R-MINE regimen

International

R-MINE regimen en Espanol

R-MINE regimen en Francais

Business

R-MINE regimen in the Marketplace

Patents on R-MINE regimen

Experimental / Informatics

List of terms related to R-MINE regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: Rituximab-Mesna-Ifosfamide-Novantrone-Etoposide regimen

Overview

R-MINE regimen refers to a regimen consisting of rituximab, mesna, ifosfamide, mitoxantrone, and etoposide used to treat relapsed or refractory Hodgkin's lymphoma and non-Hodgkin's lymphoma.[1][2]

Regimen

RRituximab

MMesna

IIfosfamide

NMitoxantrone (Novantrone)

EEtoposide

Indications

References

  1. 1.0 1.1 Fan Y, Huang ZY, Luo LH, Yu HF (2005). "[MINE regimen for patients with relapsed or chemo-resistant invasive non-Hodgkin's lymphoma]". Ai Zheng. 24 (12): 1503–6. PMID 16351801.
  2. "NCI Thesaurus".
  3. "NCI Thesaurus".